neutrophil-lymphocyte ratio (NLR)

Potential biomarkers for kidney cancer

By Sharon Deveson Kell|2022-11-29T08:57:14+00:0029 Nov 2022|Drug treatments|

Immunotherapy medicines have dramatically changed the way advanced (metastatic) kidney [...]

Comments Off

Neutrophil-lymphocyte ratio as a prognostic biomarker in high-risk locally advanced kidney cancer

By Sharon Kell|2020-07-03T09:28:40+00:003 Jul 2020|Uncategorized|

An analysis of the data collected during the S-TRAC study, [...]

Comments Off

Neutrophil-lymphocyte ratio for predicting survival in sarcomatoid kidney cancer

By Sharon Kell|2019-12-18T09:37:12+00:0018 Dec 2019|Cancer news|

A recent study of 230 patients with sarcomatoid renal cell [...]

Comments Off

Neutrophil-lymphocyte ratio may predict survival following surgery for kidney cancer

By Sharon Kell|2018-09-20T07:37:59+00:0020 Sep 2018|Cancer news|

A recent study published in European Urology Focus reports that the [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Web Design by Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org